Kana Shibata - Bioscience - Best Researcher Award

Osaka University - Japan

AUTHOR PROFILE

SCOPUS

🔬 RESEARCH EXPERTISE IN ONCOLOGY

Kana Shibata has dedicated many years to exploring the role of periostin in oncology. Her research has significantly contributed to understanding how periostin affects cancer progression and treatment resistance. Kana’s work spans from basic molecular studies to innovative therapeutic approaches, reflecting her commitment to advancing cancer research.

🏛️ PAST RESEARCH ACTIVITIES

Kana began her research career as a Researcher in the Department of Clinical Gene Therapy at Osaka University in May 2009. Her journey continued as the Director of the Biofunctional Analysis Department at Osaka University Venture Company, Periotherapia Co., in October 2017. Since October 2022, she has been a Project Researcher in the Department of Advanced Molecular Therapy at Osaka University’s Graduate School of Medicine, driving forward cutting-edge research on molecular therapies.

🏆 AWARDS AND RECOGNITION

Kana has been honored with several prestigious awards for her outstanding presentations and contributions to the field. She received the Best Presentation Award at The 21st Japanese Society of Anti-Aging Medicine in June 2021 and again at The 22nd Japanese Society of Anti-Aging Medicine in June 2022. Additionally, she was recognized with the YIA award at The 17th and 18th Japanese Society of Cerebro-Cardiovascular Anti-Aging Medicine in December 2021 and 2022, respectively.

📝 SELECTED PUBLICATIONS

Kana’s research has been published in numerous high-impact journals. Her notable works include articles on the importance of suppressing pathological periostin splicing variants, the development of novel treatments for chemotherapy-resistant cancer, and the effects of periostin on craniofacial growth and inflammation. Her publications are a testament to her influential role in advancing cancer research and therapy.

🔬 INNOVATIVE RESEARCH STUDIES

Kana’s research includes innovative studies such as the development of treatments for chemotherapy-resistant tongue cancer, prevention of inflammation in acute kidney injury models, and investigation of periostin’s role in triple-negative breast cancer. Her work frequently addresses complex interactions between periostin and various cancer types, offering new insights into potential therapeutic strategies.

🌍 CONTRIBUTIONS TO SCIENTIFIC COMMUNITIES

Kana Shibata’s contributions extend beyond research to impact scientific communities globally. Her involvement in international conferences and symposia highlights her active role in disseminating knowledge and collaborating with peers. Her presentations and research findings continue to shape discussions in the fields of oncology and molecular therapy.

💡 FUTURE RESEARCH DIRECTIONS

Looking ahead, Kana is focused on exploring new therapeutic avenues and refining her research on periostin. Her future work aims to further elucidate the mechanisms through which periostin influences cancer progression and resistance, potentially leading to novel treatments and improved patient outcomes.

NOTABLE PUBLICATION

Title: Periostin Splice Variants Affect Craniofacial Growth by Influencing Chondrocyte Hypertrophy
Authors: Ishihara, S., Usumi-Fujita, R., Kasahara, Y., Taniyama, Y., Ono, T.
Journal: Journal of Bone and Mineral Metabolism
Year: 2023

Title: Blocking Periostin Prevented Development of Inflammation in Rhabdomyolysis-Induced Acute Kidney Injury Mice Model
Authors: Muratsu, J., Sanada, F., Koibuchi, N., Morishita, R., Taniyama, Y.
Journal: Cells
Year: 2022

Title: Periostin Exon-21 Antibody Neutralization of Triple-Negative Breast Cancer Cell-Derived Periostin Regulates Tumor-Associated Macrophage Polarization and Angiogenesis
Authors: Fujikawa, T., Sanada, F., Taniyama, Y., Rakugi, H., Morishita, R.
Journal: Cancers
Year: 2021

Title: Periostin Short Fragment with Exon 17 via Aberrant Alternative Splicing Is Required for Breast Cancer Growth and Metastasis
Authors: Ikeda-Iwabu, Y., Taniyama, Y., Katsuragi, N., Rakugi, H., Morishita, R.
Journal: Cells
Year: 2021

Title: HGF Gene Therapy for Therapeutic Angiogenesis in Peripheral Artery Disease
Authors: Muratsu, J., Sanada, F., Taniyama, Y., Rakugi, H., Morishita, R.
Book Title: Therapeutic Angiogenesis